Individualized Medication of Voriconazole: A Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

BACKGROUND: Voriconazole (VRZ) is a second-generation triazole antifungal agent with broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily indicated for treating invasive aspergillosis. The most commonly used dose for adults is 4 mg/kg or 200 mg twice d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ken, Zhang, Xianglin, Ke, Xiaoyan, Du, Guanhua, Yang, Kehu, Zhai, Suodi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250289/
https://www.ncbi.nlm.nih.gov/pubmed/30192314
http://dx.doi.org/10.1097/FTD.0000000000000561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250289/
https://www.ncbi.nlm.nih.gov/pubmed/30192314
http://dx.doi.org/10.1097/FTD.0000000000000561

Ejemplares similares